Seroprevalence of antibodies against measles, rubella, mumps, varicella-zoster, and B. Pertussis in young adults of Madrid, Spain

被引:27
|
作者
Gonzalez-Escalada, Alba [1 ,2 ]
Garcia-Garcia, Laura [1 ,2 ]
Viguera-Ester, Pablo [1 ,2 ]
Marin-Garcia, Patricia [1 ,2 ]
Garcia, Jesus [3 ]
Gil-de-Miguel, Angel [1 ,2 ]
Gil-Prieto, Ruth [1 ,2 ]
机构
[1] Univ Rey Juan Carlos, Dept Prevent Med & Publ Hlth, Madrid, Spain
[2] Univ Rey Juan Carlos, Dept Immunol & Med Microbiol, Madrid, Spain
[3] Fuenlabrada Univ Hosp, Microbiol Unit, Madrid, Spain
关键词
seroprevalence; young adults; measles; rubella; mumps; B; Pertussis; Varicela-Zoster Virus; BORDETELLA-PERTUSSIS; SEROEPIDEMIOLOGY; VIRUS; POPULATION; CATALONIA; COUNTRIES; ASSAYS; STANDARDIZATION; EPIDEMIOLOGY; PERFORMANCE;
D O I
10.4161/hv.25127
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
In recent years, there has been an increase in the number of cases of certain immunopreventable diseases in our country. A high proportion of these have been recorded among the young adult population. The aim of this study was to determine the seroprevalence of antibodies against immunopreventable diseases with the greatest health impacts on the young adult population (19-39 y of age) in Madrid. We collected a total of 1,153 serum samples from healthy volunteers undergoing routine medical visits and used ELISA to determine the presence of IgG antibodies against measles, rubella, mumps, and varicella zoster, as well as Bordetella pertussis. The Pearson's 2 test was used to compare prevalences, the Mann-Whitney U test was used to compare means, and the Kruskal-Wallis test was applied for variables with more than 2 categories. Statistical significance was achieved with p values of < 0.05. The global prevalence of antibodies was 92.1% for measles, 94.4% for rubella, 88.3% for mumps, 92.8% for varicella zoster, and 70.2% for B. pertussis. No statistically significant differences were found between genders. The prevalence of antibodies against measles was more than 95% in the group of individuals born after 1986, and the percentage of individuals susceptible to rubella was less than 5% in women born after 1986. In spite of adequate vaccination coverage, in our region, a population of young adults exists who have not achieved the objectives of the WHO for the elimination of measles and congenital rubella syndrome.
引用
收藏
页码:1918 / 1925
页数:8
相关论文
共 50 条
  • [31] Waning of Maternal Antibodies Against Measles, Mumps, Rubella, and Varicella in Communities With Contrasting Vaccination Coverage
    Waaijenborg, Sandra
    Hahne, Susan J. M.
    Mollema, Liesbeth
    Smits, Gaby P.
    Berbers, Guy A. M.
    van der Klis, Fiona R. M.
    de Melker, Hester E.
    Wallinga, Jacco
    JOURNAL OF INFECTIOUS DISEASES, 2013, 208 (01): : 10 - 16
  • [32] Nonfebrile Seizures after Mumps, Measles, Rubella, and Varicella-Zoster Virus Combination Vaccination with Detection of Measles Virus RNA in Serum, Throat, and Urine
    Eckerle, Isabella
    Keller-Stanislawski, Brigitte
    Santibanez, Sabine
    Buderus, Stephan
    Hillmann, Matthias
    Drosten, Christian
    Eis-Huebinger, Anna Maria
    CLINICAL AND VACCINE IMMUNOLOGY, 2013, 20 (07) : 1094 - 1096
  • [33] Epidemiological analysis of immunity against vaccine-preventable diseases: rubella, measles, mumps and varicella zoster virus
    Buxbaum, S
    Doerr, HW
    Allwinn, R
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2001, 126 (46) : 1289 - 1293
  • [34] Measles, Rubella, and Varicella-Zoster Viral Antibodies and Clinical Prognosis After 20 Years in Persons with Multiple Sclerosis
    Fernandez, Manuel Miguel Guerrero
    Puerto, Antonio Sorlozano
    Barrero, Francisco J.
    Alvarez, Carmen Serrano
    Pinar, Raquel
    Fernandez, Jose Gutierrez
    NEUROLOGY, 2024, 103 (07) : S27 - S27
  • [35] Seroprevalence of varicella-zoster virus antibodies after the recent introduction of the universal childhood immunisation schedule in the Community of Madrid
    Garcia-Comas, Luis
    Ordobas Gavin, Maria
    Sanz Moreno, Juan Carlos
    Ramos Blazquez, Belen
    Gutierrez Rodriguez, M. Angeles
    Barranco Ordonez, Dolores
    ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA, 2016, 34 (10): : 633 - 638
  • [36] A Third Dose of Measles-Mumps-Rubella Vaccine to Improve Immunity Against Mumps in Young Adults
    Kaaijk, Patricia
    Wijmenga-Monsuur, Alienke J.
    van Houten, Marlies A.
    Veldhuijzen, Irene K.
    ten Hulscher, Hinke, I
    Kerkhof, Jeroen
    van der Klis, Fiona R.
    van Binnendijk, Rob S.
    JOURNAL OF INFECTIOUS DISEASES, 2020, 221 (06): : 902 - 909
  • [37] Influence of Vaccination Dose and Clinico-Demographical Factors on Antibody Titers against Measles, Rubella, Mumps, and Varicella-Zoster Viruses among University Students in Japan
    Takeuchi, Jiro
    Goto, Masashi
    Kawamura, Takashi
    Hiraide, Atsushi
    JAPANESE JOURNAL OF INFECTIOUS DISEASES, 2013, 66 (06) : 497 - 502
  • [38] Seroprevalence of antibodies against diphtheria, tetanus, measles, rubella in adults in Baden-Wurttemberg
    Zoellner, I.
    Wagner-Wiening, C.
    Reick, D.
    Fischer, S.
    Diedler, A.
    GESUNDHEITSWESEN, 2016, 78
  • [39] Analysis of seroprevalence against measles, rubella and mumps in health workers of two health departments of the Valencian Community (Spain)
    Garcia Roman, Vicente
    Tenza Iglesias, Isidra
    Duro Torrijos, Jose Luis
    Mendoza Garcia, Jose Luis
    Martinez Martinez-Carrasco, Esther
    Ronda Perez, Elena
    REVISTA ESPANOLA DE SALUD PUBLICA, 2022, 96
  • [40] Performance Characteristics of a Multiplex Flow Immunoassay for Detection of IgG-Class Antibodies to Measles, Mumps, Rubella, and Varicella-Zoster Viruses in Presumptively Immune Health Care Workers
    Theel, Elitza S.
    Sorenson, Marisa
    Rahman, Crystal
    Granger, Dane
    Vaughn, Andrew
    Breeher, Laura
    JOURNAL OF CLINICAL MICROBIOLOGY, 2020, 58 (04)